Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to improve the standard of care in case of the inhibition of lactation.
The participant qualified for the study will answer the questions contained in the survey. The patient will have her breast palpated and then will be instructed on the possible options for the inhibition of lactation. The participant, who decides to inhibit lactation with medications, will be consulted by a doctor.
Each patient will receive information of the possible ways to relieve the symptoms of overfilled breast and be able to contact with lactation consultant. The participant will also receive a card to assess the severity of symptoms in the following days. The investigators will call the patient between the third and fifth day by phone.
Once again, after 2 weeks from the beginning of the inhibition of lactation in order to ask questions contained in the survey (the course of the process, problems that occurred and the level of satisfaction with the chosen method).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pharmaceutical method- Bromocriptine | Experimental |
| |
| Pharmaceutical method- Cabergoline | Experimental |
| |
| Without medications that inhibit lactation | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bromocriptine | Drug | Bromocriptine - on the first day of treatment (1,25 mg) with morning and evening meal and then 2,5 mg dose twice a day for two weeks (14 days) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analogue Scale (VAS) | Pain assesment by Visual Analogue Scale (VAS scale), range 0-10, higher numbers represents worse outcome. | from the 1st day of the inhibition of lactation to 14th day of process |
| Evaluation of breast status | Daily evaluation of breast status. Are they: heavy, full, swollen (engorged), warmed up, hard, irregular, leaking. Gradations of symptoms intensity by using (+) and (-) where:
| from the 1st day of the inhibition of lactation to 14th day of process |
| Symptoms in association with the ingestion of medicines that inhibit lactation. |
Symptoms that occurred are marked with a "+". | from the 1st day of the inhibition of lactation to 14th day of process |
| Breast palpation | • Size (each one separately; left and right breast)
The correct answer is marked with a "+". • Anomalies (each one separately; left and right breast)
The correct answer is marked with a "+". | 1st day of including in the study |
| Survey: 1st day of including in the study | Questions about:
| 1st day of including in the study |
| Measure | Description | Time Frame |
|---|---|---|
| Survey: 3rd-5th day of lactation suppression | Question about: • ailments, problems and extra methods of relief of symptoms | 3rd-5th day of lactation suppression |
| Survey: 14th-16th day of lactation suppression |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alicja Misztal, MSc | Contact | +48 513 007 355 | alicja.misztal@gmail.com | |
| Kinga Osuch, MSc | Contact | + 48 500 003 697 | ki.osuch@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Dorota Sys, PhD | Centre of Postgraduate Medical Education | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Żelazna Medical Centre | Recruiting | Warsaw | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001971 | Bromocriptine |
| D000077465 | Cabergoline |
| D012252 | Natural Family Planning Methods |
| ID | Term |
|---|---|
| D004879 | Ergotamines |
| D004876 | Ergot Alkaloids |
| D000470 | Alkaloids |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Cabergoline | Drug | Cabergoline - one dose (1 mg) on the first day after childbirth or 0.25 mg dose every 12 hours for 2 days |
|
|
| Natural methods | Other | milk expression, cold compress, cabbage leaf compresses, mild painkiller- e.g. ibuprofen, supportive bra, sage tea. |
|
Questions about:
| 14th-16th day of lactation suppression |
| D004873 |
| Ergolines |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D003267 | Contraception |
| D012099 | Reproductive Techniques |
| D013812 | Therapeutics |